Mills M, Kanavos P. Healthcare Payer Perspectives on the Assessment and Pricing of Oncology Multi-Indication Products: Evidence from Nine OECD Countries. Pharmacoecon Open. 2023 Mar 23. doi: 10.1007/s41669-023-00406-1 Show Publication

Mills, M. HTA Barriers for Conditional Approval Drugs. PharmacoEconomics (2023). https://doi.org/10.1007/s40273-023-01248-9 Show Publication

Mills M, Michaeli D, Miracolo A, Kanavos P. Launch sequencing of pharmaceuticals with multiple therapeutic indications: evidence from seven countries. BMC Health Services Research. 2023 Feb;23(1):150. DOI: 10.1186/s12913-023-09095-2. PMID: 36782175; PMCID: PMC9923892 Show Publication

Mills M, Kanavos P. How do HTA agencies perceive conditional approval of medicines? Evidence from England, Scotland, France and Canada. Health Policy. 2022 Nov;126(11):1130-1143. doi: 10.1016/j.healthpol.2022.08.005 Epub 2022 Aug 9. PMID: 3605019 Show Publication

Mills M, Kanavos P. Do pharmaceutical budgets deliver financial sustainability in healthcare? Evidence from Europe. Health Policy. 2020 Mar 1;124(3):239-51 Show Publication

Mills M, Boekstein N, Mackintosh M, Kanavos P. Towards High Quality Health Care and Sustainable Financing–the Role of Health Care Programmes. Global Policy. 2017. 8(S2):46-59 Show Publication

Michaeli, D. T., Mills, M., & Kanavos, P. Value and price of multi-indication cancer drugs in the USA, Germany, France, England, Canada, Australia, and Scotland. Applied Health Economics and Health Policy. 2022 1-12 Show Publication

Michaeli, D. T., Mills, M., Michaeli, T., Miracolo, A., & Kanavos, P. Initial and supplementary indication approval of new targeted cancer drugs by the FDA, EMA, Health Canada, and TGA. Investigational New Drugs. 2022 1-12 Show Publication

Habl, C, Laschkolnig, A, Habimana, K, Stürzlinger, H, Röhrling, I, Bobek, J, Kanavos, P, Visintin, E, Fontrier, A, & Mills, M. Study on impact analysis of policy options for strengthened EU cooperation on Health Technology Assessment (HTA): annexes. European Commission. Brussels. 2017. ISBN 978-92-79-77939-8 Show Publication